Fecal transplant treatment for patients with recurrent Clostridioides difficile is more effective and more likely to prevent bloodstream infections than antibiotics, according to a study published Nov. 5 in Annals of Internal Medicine.
Researchers analyzed 290 inpatients with recurrent C. diff infections at an academic medical center in a cohort study. Of the 109 patients treated with fecal transplant, 4.5 percent developed bloodstream infections, while 22 percent of the 181 patients receiving antibiotics developed bloodstream infections.
Patients receiving fecal transplants had a 23 percent lower bloodstream infection risk, along with 14 fewer days of hospitalization compared to the antibiotic group.
To view the full study, click here.